Cancer Research Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 6069-6072, December 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuhausen, S. L.
Right arrow Articles by Marshall, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neuhausen, S. L.
Right arrow Articles by Marshall, C. J.

Loss of Heterozygosity in Familial Tumors from Three BRCA1-linked Kindreds1

Susan L. Neuhausen2 and C. Jay Marshall

Departments of Medical Informatics [S. N.] and Pathology [C. J. M.], University of Utah School of Medicine, Salt Lake City, Utah 84132

BRCA1, a breast-ovarian cancer susceptibility gene which has been localized to 17q21, appears to be a tumor suppressor gene based on evidence from loss of heterozygosity (LOH) studies. We analyzed 14 ovarian and breast tumors from BRCA1 carriers and 1 sporadic breast tumor from 3 kindreds for 17q21 LOH. Thirteen of the 14 tumors from gene carriers exhibited LOH of the wild-type allele. Tumors from one gene carrier and the sporadic breast case did not exhibit any LOH in the region. There was loss of the wild-type allele from both maternally and paternally derived chromosomes, therefore excluding the possibility of genomic imprinting and providing further evidence that BRCA1 is a tumor suppressor. Three tumors showed interstitial LOH in the region, and thus established the utility of familial tumors in refining a region surrounding a tumor suppressor gene in a manner analogous to using genetic recombinants.

1 This work was supported by Grants CA-48711 and CA-55914 from the NIH.

2 To whom requests for reprints should be addressed, at Genetic Epidemiology, 420 Chipeta Way, Rm 180, Salt Lake City, UT 84108.

Received 8/31/94. Accepted 10/19/94.




This article has been cited by other articles:


Home page
JCOHome page
A. D. Spearman, K. Sweet, X.-P. Zhou, J. McLennan, F. J. Couch, and A. E. Toland
Clinically Applicable Models to Characterize BRCA1 and BRCA2 Variants of Uncertain Significance
J. Clin. Oncol., November 20, 2008; 26(33): 5393 - 5400.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. M. Swisher, W. Sakai, B. Y. Karlan, K. Wurz, N. Urban, and T. Taniguchi
Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance
Cancer Res., April 15, 2008; 68(8): 2581 - 2586.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
F. Meric-Bernstam
Heterogenic Loss of BRCA in Breast Cancer: The "Two-Hit" Hypothesis Takes a Hit
Ann. Surg. Oncol., September 1, 2007; 14(9): 2428 - 2429.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. A. King, W. Li, E. Brogi, C. J. Yee, M. L. Gemignani, N. Olvera, D. A. Levine, L. Norton, M. E. Robson, K. Offit, et al.
Heterogenic Loss of the Wild-Type BRCA Allele in Human Breast Tumorigenesis
Ann. Surg. Oncol., September 1, 2007; 14(9): 2510 - 2518.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Zhang and S. N. Powell
The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair
Mol. Cancer Res., October 1, 2005; 3(10): 531 - 539.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Xiong, S. Fan, Q. Meng, L. Schramm, C. Wang, B. Bouzahza, J. Zhou, B. Zafonte, I. D. Goldberg, B. R. Haddad, et al.
BRCA1 Inhibition of Telomerase Activity in Cultured Cells
Mol. Cell. Biol., December 1, 2003; 23(23): 8668 - 8690.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Staff, J. Isola, and M. Tanner
Haplo-insufficiency of BRCA1 in Sporadic Breast Cancer
Cancer Res., August 15, 2003; 63(16): 4978 - 4983.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Fan, Y. X. Ma, C. Wang, R.-Q. Yuan, Q. Meng, J.-A. Wang, M. Erdos, I. D. Goldberg, P. Webb, P. J. Kushner, et al.
p300 Modulates the BRCA1 Inhibition of Estrogen Receptor Activity
Cancer Res., January 1, 2002; 62(1): 141 - 151.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. MAGDINIER, L.-M. BILLARD, G. WITTMANN, L. FRAPPART, M. BENCHAÏB, G. M. LENOIR, J. F. GUÉRIN, and R. DANTE
Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells
FASEB J, August 1, 2000; 14(11): 1585 - 1594.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. K. MacLachlan, K. Somasundaram, M. Sgagias, Y. Shifman, R. J. Muschel, K. H. Cowan, and W. S. El-Deiry
BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression
J. Biol. Chem., January 28, 2000; 275(4): 2777 - 2785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-C. Suen and P. E. Goss
Transcription of BRCA1 Is Dependent on the Formation of a Specific Protein-DNA Complex on the Minimal BRCA1 Bi-directional Promoter
J. Biol. Chem., October 29, 1999; 274(44): 31297 - 31304.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Ruffner, W. Jiang, A. G. Craig, T. Hunter, and I. M. Verma
BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site
Mol. Cell. Biol., July 1, 1999; 19(7): 4843 - 4854.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
V. L. Cressman, D. C. Backlund, E. M. Hicks, L. C. Gowen, V. Godfrey, and B. H. Koller
Mammary Tumor Formation in p53- and BRCA1-deficient Mice
Cell Growth Differ., January 1, 1999; 10(1): 1 - 10.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
F. Durocher, J. Simard, J. Ouellette, V. Richard, F. Labrie, and G. Pelletier
Localization of BRCA1 Gene Expression in Adult Cynomolgus Monkey Tissues
J. Histochem. Cytochem., September 1, 1997; 45(9): 1173 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Scully, S. F. Anderson, D. M. Chao, W. Wei, L. Ye, R. A. Young, D. M. Livingston, and J. D. Parvin
BRCA1 is a component of the RNA polymerase II holoenzyme
PNAS, May 27, 1997; 94(11): 5605 - 5610.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
T Ludwig, D L Chapman, V E Papaioannou, and A Efstratiadis
Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos.
Genes & Dev., May 15, 1997; 11(10): 1226 - 1241.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Thomas, M. Smith, B. Rubinfeld, M. Gutowski, R. P. Beckmann, and P. Polakis
Subcellular Localization and Analysis of Apparent 180-kDa and 220-kDa Proteins of the Breast Cancer Susceptibility Gene, BRCA1
J. Biol. Chem., November 8, 1996; 271(45): 28630 - 28635.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
T M Smith, M K Lee, C I Szabo, N Jerome, M McEuen, M Taylor, L Hood, and M C King
Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.
Genome Res., November 1, 1996; 6(11): 1029 - 1049.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.